JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
+$2.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.05B |
| 3 |
AbbVie
ABBV
|
+$1.78B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.63B |
| 5 |
Exxon Mobil
XOM
|
+$1.6B |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.92B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 3 |
Tesla
TSLA
|
+$1.22B |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.13B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.03B |
Sector Composition
| 1 | Technology | 17.24% |
| 2 | Healthcare | 11.68% |
| 3 | Financials | 11.59% |
| 4 | Consumer Discretionary | 9.21% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4501
Ventyx Biosciences
VTYX
$164M
| $103K | ﹤0.01% |
7,593
-55,717
| -88% | -$756K |
|
4502
Zevia
ZVIA
$184M
| $103K | ﹤0.01% |
22,531
-7,202
| -24% | -$32.9K |
|
|
HYFT
4503
MindWalk Holdings Corp. Common Stock
HYFT
$102M
| $102K | ﹤0.01% |
19,904
-40,217
| -67% | -$206K |
|
|
KG
4504
Kestrel Group, Ltd.
KG
$211M
| $102K | ﹤0.01% |
2,096
-2,959
| -59% | -$144K |
|
4505
RxSight
RXST
$381M
| $102K | ﹤0.01% |
8,227
+2,820
| +52% | +$35K |
|
|
VIRX
4506
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $102K | ﹤0.01% |
21,441
+4,210
| +24% | +$20K |
|
|
CPARW
4507
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
| – | – |
0
| – | – |
|
4508
Aldeyra Therapeutics
ALDX
$324M
| $101K | ﹤0.01% |
22,835
+4,012
| +21% | +$17.7K |
|
4509
Ceco Environmental
CECO
$1.7B
| $101K | ﹤0.01% |
18,423
-24,882
| -57% | -$136K |
|
4510
ORIX
IX
$30B
| $101K | ﹤0.01% |
5,090
-195
| -4% | -$3.87K |
|
4511
SPDR Dow Jones International Real Estate ETF
RWX
$308M
| $101K | ﹤0.01% |
2,960
-1
| -0% | -$34 |
|
4512
VirTra
VTSI
$62.9M
| $101K | ﹤0.01% |
16,618
-31,766
| -66% | -$193K |
|
4513
iShares US Industrials ETF
IYJ
$1.67B
| $100K | ﹤0.01% |
945
-8,987
| -90% | -$951K |
|
|
SY
4514
So-Young International
SY
$374M
| $100K | ﹤0.01% |
50,682
-405
| -0.8% | -$799 |
|
4515
Tilly's
TLYS
$57.3M
| $100K | ﹤0.01% |
10,631
-21,186
| -67% | -$199K |
|
|
VMCAU
4516
DELISTED
Valuence Merger Corp. I Unit
VMCAU
| $100K | ﹤0.01% |
+10,000
| New | +$100K |
|
4517
ATAI Life Sciences
ATAI
$992M
| $99K | ﹤0.01% |
19,488
+5,357
| +38% | +$27.2K |
|
4518
Brown-Forman Class A
BF.A
$13.2B
| $99K | ﹤0.01% |
1,577
+363
| +30% | +$22.8K |
|
4519
LCNB Corp
LCNB
$223M
| $99K | ﹤0.01% |
5,621
-5,456
| -49% | -$96.1K |
|
4520
Paysafe
PSFE
$827M
| $99K | ﹤0.01% |
2,434
-171
| -7% | -$6.96K |
|
4521
Smith Micro Software
SMSI
$14.7M
| $99K | ﹤0.01% |
3,299
-4,519
| -58% | -$136K |
|
4522
Viking Therapeutics
VKTX
$2.79B
| $99K | ﹤0.01% |
32,893
+5,606
| +21% | +$16.9K |
|
|
HCIIU
4523
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
| $99K | ﹤0.01% |
9,999
| – | – |
|
4524
Mistras Group
MG
$299M
| $98K | ﹤0.01% |
14,850
-12,481
| -46% | -$82.4K |
|
|
CLPR
4525
Clipper Realty
CLPR
$70.6M
| $97K | ﹤0.01% |
10,705
-10,330
| -49% | -$93.6K |
|